Alpha 1 Global

Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1 Antitrypsin Treatment

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today announced that the Company has submitted to the U.S. Food and Drug Administration …

Read More

Alpha One Foundation (Ireland) Outlines Case for Life-changing Therapy to the Oireachtas Joint Committee

The Oireachtas Joint Committee on Health met on July 12th to discuss the process for the review and approval of Orphan Drugs.  The Alpha One …

Read More

Clinical Utility of Alpha-1 Proteinase Inhibitor in the Management of Adult Patients with Severe Alpha-1 Antitrypsin Deficiency: a Review of the Current Literature

David G Parr, Beatriz Lara Department of Respiratory Medicine, Cardio-Respiratory Division, University Hospital Coventry, Coventry, UK Abstract: Alpha-1 antitrypsin (AAT) functions primarily to inhibit neutrophil elastase, …

Read More

An Alpha Nicotine Addict’s Quest for a New Life in Newfoundland and Labrador

By Heidi Wicks Diagnosed with the lungs of a 126-year-old man from years of smoking and a rare genetic lung disorder, Ryan Taylor moved home …

Read More

5-year-old Alpha Becomes the Face of Australia’s DonateLife Week

If you still aren’t sure about whether or not to become an organ donor, look into the eyes of Archer Irwin. The five-year-old from Wodonga has become …

Read More

How’s Your Day – Making the Difference with Plasma Proteins

The “How’s Your Day” series is produced by Plasma Protein Therapeutics Association (PPTA) as part of a rare disease awareness campaign. Frank Willersinn (Alpha-1 Global …

Read More

Foundation President and CEO Urges Alphas to Find Their Place in the Alpha-1 Community

CHICAGO, Illinois – Henry Moehring, president and CEO of the Alpha–1 Foundation, presided over the 26th and largest National Education Conference of the Alpha–1 community …

Read More

OncBioMune Pharmaceuticals Schedules First Patient with AAT Deficiency for Treatment in Mexico

Jun 28, 2017 (Marketwired via COMTEX) — BATON ROUGE, LA–(Marketwired – June 28, 2017) – OncBioMune Pharmaceuticals, Inc. (otcqb:OBMP) (“OncBioMune” or the “Company”), a revenue-stage …

Read More

Issue #4 of the Alpha-1 Global Physician & Researcher eNews Now Available

To view Issue #4 of the Alpha-1 Global Physician & Researcher eNews, click here.  

Read More

Alpha Artist Featured at Albany Center Gallery’s New Photography Exhibit – “Makers 365”

A new photographic exhibit opened this week at the Albany Center Gallery. It’s called “Makers 365.” It’s 365 photos of people who are artists living …

Read More

Alpha-1 Around The Globe

Click on the country flags below to learn more about country specific contact and general information, access to care, and available resources

Join Our Newsletter

Subscribe to stay in touch with the latest in Alpha-1 Global